/VOQP

VOQP Stock - VioQuest Pharmaceuticals, Inc.

Q: What is the analyst price target for VOQP?

Analyst price target information is not currently available for VOQP.

Q: What is VOQP's market cap?

Market capitalization information is not currently available for VOQP.

Healthcare|Biotechnology|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for VOQP

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2003

FY2004

FY2005

FY2006

FY2007

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.11

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2007	FY2006	FY2005	FY2004	FY2003
Revenue	N/A	N/A	$3.80M	$1.49M	$669,036
Gross Profit	N/A	N/A	$1.38M	$647,495	$472,991
Gross Margin	N/A	N/A	36.2%	43.6%	70.7%
Operating Income	$9.74M	$5.28M	$13.11M	$4.06M	$2.03M
Net Income	$-10,891,741	$-8,271,164	$-12,834,629	$-4,023,558	$-2,018,400
Net Margin	N/A	N/A	-337.3%	-270.9%	-301.7%
EPS	$-2.33	$-2.08	$-5.82	$-2.35	$-1.62

Company Overview

VioQuest Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of clinical stage drug therapies for the treatment of oncology and infectious diseases. Its lead product includes Xyfid, which is under development for the treatment and prevention of hand-foot syndrome. The company's products also consist of VQD-002, a nucleoside analog that is in Phase I clinical trials for the treatment of cancer; and Lenocta, a small molecule inhibitor of various protein tyrosine phosphatases, which is in Phase IIa clinical trials for the treatment of melanoma, renal cell carcinoma, and other solid tumors. VioQuest Pharmaceuticals also provides chiral products, technology, and custom synthesis development services to pharmaceutical and fine chemical companies in various stages of a products' lifecycle. The company was founded in 2000 and is headquartered in Basking Ridge, New Jersey.

Earnings History & Surprises

VOQP

Beat Rate

Last 1 quarters

Avg Surprise

-66.7%

EPS vs Estimate

Beats / Misses

0/1

Last 12 quarters

Latest EPS

$-0.50

Q3 2006

EPS Surprise History

Q3 06

-66.7%

$-0.50vs$-0.30

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2006	Aug 11, 2006	$-0.30	$-0.50	-66.7%	✗ MISS

Frequently Asked Questions about VOQP

What is VOQP's current stock price?

VioQuest Pharmaceuticals, Inc. (VOQP) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for VOQP?

No analyst price targets are currently available for this stock.

What sector is VioQuest Pharmaceuticals, Inc. in?

VioQuest Pharmaceuticals, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the OTC exchange.

What is VOQP's market cap?

VioQuest Pharmaceuticals, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does VOQP pay dividends?

No, VioQuest Pharmaceuticals, Inc. does not currently pay a dividend to shareholders.